Ann: Appointment of Keith Koby as President, North America, page-14

the contract with RHC was up on the 21/1/2023 according to the announcement from last year. If you allow for weekends etc that put it for Monday this week. Currently we haven’t seen an extension hit the news desk so any delay is generally seen as a fail by most people in markets across lots of stocks like HMD etc. Having said that I’m sure that Phantom can enlighten us all to wether or not mums are still being enrolled. If they were enrolled in January then it blows the mind that renewal won’t happen however life has a perplexing ability to spin things on their head… signatures aren’t dry on paper and cash isn’t on the barrelhead so maybe there’s no deal?

The insider trading update followed the next day by the appointment of a pretty big hitter can really only be seen as a positive I would imagine? Keith is the real deal and could take a position in pretty much any health business but he’s come back in with Ron to move another of his tiny companies forward. I cannot see his appointment as anything other than a win. I was on a phone call yesterday morning about his appointment and I was just pumped to see it come out as an announcement. He is on board for very specific reasons which are immediately apparent by a cursory glance of his CV. He is a growth specialist in medical technology. Pure and simple. He’s the right guy for a growth company involved in medical tech…. That is HMD to a Tee…

The prospect of a further capital raise cannot be ruled out until there is visibility from the quarterly 4C etc. until there is clarity on revenue then how does this guy get paid etc? e-Lōvu is enrolling mums and seems to be getting some traction so more will come from them if they are being truthful, I didn’t end up invested in them so I’m unsure as to where they are at this moment in time however they are still talking a big game… e-Lōvu prepays so the 4C should show some money from them and then next quarter will be more as they ramp up. This quarter should show something from JHC but probably not much from Melbourne Mums as they kick off this week or next so that will be in the next 4C too.

So what is the catalyst here? It is probably a situation where sentiment is on the uncertain side which will send the price down, which we have seen. The driver for upward change is RHC first and then e-Lōvu second. Should KC remember that 40% of Nanosonics US revenue was coming from Ob/Gyn contracts then he might also remember the details of the people to contact about a remote maternal monitoring platform that can now be reimbursed by health insurance… that would be a handy scenario to play out.

Dunno mate…. Lots of the right things tempered by some doubt, delays and lack of clarity on revenue means it’s probably 12-15c range for a little bit… could
leapfrog if we get the right info but currently we have the wrong or at least indecisive signals at play. What a fun little stock to keep you guessing!!